Insider · CIK 0001248093

KAKKIS EMIL D

Reports to the SEC for 2 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001248093

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-16	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+76.7K sh	—	—	735,739
2026-04-16	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+133K sh	—	—	132,693
2026-03-02	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−54.4K sh	$22.80	−$1.24M	658,994
2026-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+71.2K sh	—	—	712,908
2025-03-03	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−73.4K sh	$42.10	−$3.09M	641,731
2025-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+43.3K sh	—	—	607,873
2025-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+107K sh	—	—	715,165
2025-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+78.4K sh	—	—	78,448
2025-02-28	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−25K sh	$42.48	−$1.06M	2,158,985
2024-12-30	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−11.7K sh	$42.23	−$495K	2,183,985
2024-12-10	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−8,273 sh	$50.00	−$414K	2,195,712
2024-12-09	RAREUltragenyx Pharmaceutical Inc.G Gift	Director, President & CEO	GGift	−20K sh	—	—	2,203,985
2024-09-03	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−20K sh	$55.85	−$1.12M	2,223,985
2024-08-06	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−20K sh	$50.17	−$1M	2,243,985
2024-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+38.4K sh	—	—	578,198
2024-03-01	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	Director, President & CEO	FTax Payment	−17.4K sh	$53.69	−$935K	560,781
2024-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+3,132 sh	—	—	563,913
2024-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+70.1K sh	—	—	70,094
2024-02-07	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−30K sh	$45.00	−$1.35M	539,770
2023-12-29	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−30K sh	$47.87	−$1.44M	569,770
2023-10-19	RAREUltragenyx Pharmaceutical Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+47.9K sh	$6.86	+$328K	647,029
2023-10-19	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−47.9K sh	$33.52	−$1.6M	599,743
2023-10-19	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−47.9K sh	—	—	0
2023-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+8,716 sh	—	—	569,406
2023-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+46.2K sh	—	—	615,606
2023-03-01	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	Director, President & CEO	FTax Payment	−16.1K sh	$45.65	−$737K	599,176
2023-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+83.5K sh	—	—	83,500
2022-12-30	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−19.6K sh	$45.57	−$892K	541,108
2022-03-01	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	Director, President & CEO	FTax Payment	−12.2K sh	$67.37	−$819K	582,185
2022-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+52K sh	—	—	634,226
2022-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+92.4K sh	—	—	92,360
2021-12-10	RAREUltragenyx Pharmaceutical Inc.G Gift	Director, President & CEO	GGift	−50K sh	—	—	2,209,741
2021-10-14	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	Director, President & CEO	FTax Payment	−853 sh	$81.00	−$69.1K	594,347
2021-05-06	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	Director, President & CEO	FTax Payment	−852 sh	$115.71	−$98.6K	595,200
2021-05-03	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−30K sh	$107.80	−$3.23M	2,259,741
2021-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+18K sh	—	—	596,941
2021-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	Director, President & CEO	AAward	+15.5K sh	—	—	612,394
2021-03-01	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	Director, President & CEO	FTax Payment	−16.3K sh	$142.47	−$2.33M	596,052
2021-03-01	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−30K sh	$141.80	−$4.25M	2,289,741
2021-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+36K sh	—	—	36,000
2021-01-04	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−30K sh	$136.90	−$4.11M	2,329,741
2020-11-27	RAREUltragenyx Pharmaceutical Inc.G Gift	Director, President & CEO	GGift	−31.2K sh	—	—	578,941
2020-11-19	RAREUltragenyx Pharmaceutical Inc.G Gift	Director, President & CEO	GGift	−10K sh	—	—	2,349,741
2020-11-02	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−30K sh	$96.82	−$2.9M	2,359,741
2020-10-14	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	Director, President & CEO	FTax Payment	−852 sh	$92.69	−$79K	610,189
2020-09-01	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−30K sh	$82.63	−$2.48M	2,389,741
2020-07-13	RAREUltragenyx Pharmaceutical Inc.S Sale	Director, President & CEO	SSale	−40K sh	$85.35	−$3.41M	2,419,741
2020-06-01	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	Director, President & CEO	FTax Payment	−1,334 sh	$69.38	−$92.6K	611,041
2020-05-27	RAREUltragenyx Pharmaceutical Inc.G Gift	Director, President & CEO	GGift	−40.4K sh	—	—	578,941
2020-05-22	RAREUltragenyx Pharmaceutical Inc.G Gift	Director, President & CEO	GGift	−100K sh	—	—	2,349,741

Recent filings

Accepted (ET)
Apr 204
KAKKIS EMIL D0001193125-26-164308
SEC(opens sec.gov)
Mar 34
KAKKIS EMIL D0001193125-26-089278
SEC(opens sec.gov)
Mar 44
KAKKIS EMIL D0000950170-25-032779
SEC(opens sec.gov)
Dec 314
KAKKIS EMIL D0000950170-24-141485
SEC(opens sec.gov)
Dec 114
KAKKIS EMIL D0000950170-24-135521
SEC(opens sec.gov)
Sep 54
KAKKIS EMIL D0000950170-24-103811
SEC(opens sec.gov)
Aug 74
KAKKIS EMIL D0000950170-24-092608
SEC(opens sec.gov)
Mar 54
KAKKIS EMIL D0000950170-24-026625
SEC(opens sec.gov)
Feb 84
KAKKIS EMIL D0001209191-24-002989
SEC(opens sec.gov)
Jan 24
KAKKIS EMIL D0001209191-24-000071
SEC(opens sec.gov)

Companies

Address

C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT

NOVATO, CA, 94949